ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,159, issued on Oct. 20, was assigned to IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (Seoul, South Korea).
"Glycyrrhizin-branched polyethylene glycol conjugate for treating cancer" was invented by Dong Yun Lee (Seoul, South Korea) and Min Su Kim (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a glycyrrhizin-branched polyethylene glycol conjugate and a use thereof for treating cancer, wherein the glycyrrhizin-branched PEG conjugate exhibits anti-cancer effects better than those of glycyrrhizin and increases blood half-life, and thus can be effectively used for treating ca...